Raab & Moskowitz Asset Management’s GSK GSK Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-358	Closed	-$21K	–	292
2019 Q4	$21K	Buy	+358	New	+$19.9K	0.01%	336
2018 Q4	–	Sell	-360	Closed	-$18K	–	298
2018 Q3	$18K	Buy	+360	New	+$18.3K	0.01%	363
2015 Q1	–	Sell	-832	Closed	-$44K	–	218
2014 Q4	$44K	Buy	+832	New	+$46.5K	0.03%	206

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Raab & Moskowitz Asset Management's GSK Position: Q1 2020 in Review

Raab & Moskowitz Asset Management sold out of GSK (GSK) in Q1 2020, closing a stake of 358 shares — an estimated $21K sold.

Raab & Moskowitz Asset Management first reported a position in GSK in Q4 2014 and held it in 3 quarters. The position peaked at $44K in Q4 2014. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Raab & Moskowitz Asset Management reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
Raab & Moskowitz Asset Management sold 358 GSK shares in Q1 2020, an estimated $21K.
Raab & Moskowitz Asset Management first reported a position in GSK in Q4 2014 and held it in 3 quarters.
Raab & Moskowitz Asset Management's GSK position peaked at $44K in Q4 2014.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.